| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35F3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35F3 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of SLC35F3 mRNA | 22230336 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of SLC35F3 mRNA | 17562736 |
| C015001 | arsenite | arsenite results in increased methylation of SLC35F3 promoter | 23974009 |
| C487081 | belinostat | belinostat results in decreased expression of SLC35F3 mRNA | 27188386 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of SLC35F3 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of SLC35F3 mRNA | 27392435 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of SLC35F3 mRNA | 23649840 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of SLC35F3 mRNA | 23649840 |
| C412815 | GW 4064 | GW 4064 results in decreased expression of SLC35F3 mRNA | 26655953 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of SLC35F3 mRNA | 27392435 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of SLC35F3 mRNA | 23649840 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of SLC35F3 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of SLC35F3 mRNA" | 25554681 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA" | 25510870 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35F3 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of SLC35F3 mRNA | 26272509 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC35F3 mRNA | 19710929 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of SLC35F3 mRNA | 23557933 |
| D010938 | Plant Oils | Plant Oils results in decreased expression of SLC35F3 mRNA | 23370395 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of SLC35F3 mRNA | 26079696 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of SLC35F3 mRNA | 22714537 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SLC35F3 mRNA | 21570461 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of SLC35F3 mRNA | 23724009 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of SLC35F3 mRNA | 23179753 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of SLC35F3 mRNA | 28001369 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of SLC35F3 gene | 29154799 |